PeakShares LLC’s CVS Health CVS Stock Holding History

PeakShares LLC’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$39.7K	–	118
2025 Q4	$39.7K	Buy	+500	New	+$39.4K	0.04%	105

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PeakShares LLC's CVS Position: Q1 2026 in Review

PeakShares LLC sold out of CVS Health (CVS) in Q1 2026, closing a stake of 500 shares — an estimated $39.7K sold.

PeakShares LLC first reported a position in CVS in Q4 2025 and held it in 1 quarter. The position peaked at $39.7K in Q4 2025. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

PeakShares LLC reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
PeakShares LLC sold 500 CVS Health shares in Q1 2026, an estimated $39.7K.
PeakShares LLC first reported a position in CVS Health in Q4 2025 and held it in 1 quarter.
PeakShares LLC's CVS Health position peaked at $39.7K in Q4 2025.
1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on PeakShares LLC's 13F filing for Q1 2026, filed 6 May 2026.